Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
A promising post from Rich Ford indicating Astute Electronics will be using Osmium. Astute Electronics had turnover of £287m in 2022 up from £119m in 2021.
“This gamechanging technology is the best thing to have happened to power supply design for decades in my opinion. Astute Electronics are moving forward with this technology and more amazing news will follow as Pulsiv surge forward”
hTTps://www.linkedin.com/feed/update/urn:li:activity:7155324198054207489/
This is from the full year results
“CamGraPhIC is another company making excellent technical and commercial progress with its graphene-based photonics technology. The company was already working closely with major multinationals in data and telecommunications but is now starting to gain traction from beyond the sector and from governmental organisations.”
They've now appointed an interim CEO, as per this on LinkedIn.
"Ben Jensen
It's great to be able to share that I’ve started a new position as Interim Chief Executive Officer at CamGraPhIC Ltd!
I'm really looking forward to sharing some of the amazing progress we have made over the last few years and talking about how we are scaling Graphene Integrated Photonics (GIP) into a high volume foundry process.
Alan Thompson
Development & Government Affairs and Relations | Development Bank | Strategy / Value Proposition
Congratulations Ben! Look forward to continuing the overlap with Space applications.
Ben Jensen
Author
Thanks Alan. There’s definitely a good overlap with this technology."
Here's FIPP's RNS re new investment into Alusid from Octopus and a potential IPO for Alusid later this year:
Https://uk.advfn.com/stock-market/london/frontier-ip-FIPP/share-news/Frontier-IP-Group-plc-Octopus-invest-in-Alusid-as-part-of-equity-funding/93094966
Commentary in the Times:
Https://www.thetimes.co.uk/article/21alusid-xr5jkdkfv
"A company that turns recycled industrial waste into premium-quality tiles has been valued at £9.5 million before a potential stock market float, after raising more than £1.1 million from investors.
Alusid, which makes handmade tiles and surfaces such as table-tops at its factory in Preston, Lancashire, said that £500,000 of that sum had come from Octopus Investments, the financial services business that manages more than £13 billion of private equity, venture capital and listed company assets.
Proceeds from the initial public offering will be used to support the company’s expansion into new product ranges and territories. Alusid, which is developing hard-wearing floor tiles that are expected to be launched commercially this year, is also in talks with potential distributors in Scandinavia and northern Europe.
Last year the business signed a multi-year deal with Topps Tiles and it has produced its first range of mass-manufactured tiles for the retailer, with further product launches expected. Other customers include Pret a Manger, the BBC and H&M, the fashion group.
Alasdair Bremner, 43, the company’s chief executive, said: “We are delighted with the investment and support from Octopus and look forward to working with them. This is an important year for Alusid as we launch our first 98.5 per cent-recycled, low-carbon floor tile, expand our geographical reach and seek to become a public company.”
Bremner co-founded the business with David Binns, now its creative director, after being awarded an Arts Council grant to explore the “aesthetics of waste’ while working as an academic in the ceramics department at the University of Central Lancashire.
Neil Cragg, the chief executive of Frontier IP, which specialises in turning intellectual property into commercially viable ventures and which holds a 35.4 stake in Alusid, said: “The investment from Octopus represents important validation for Alusid, its capital-efficient business model and the quality of its products, made from a minimum of 91 per cent-recycled material, among the highest levels in the industry, if not the highest.”
And here's a new video from Alusid's CEO about the Octopus investment and upcoming IPO:
Https://www.youtube.com/watch?v=jwyMmymdAXo
"Alasdair Bremner, chief executive, of Alusid, a portfolio company of Frontier IP Group PLC, joined Proactive's Stephen Gunnion after the company raised £1.1 million, including £500,000 from Octopus Investments.
Bremner said the company will use the funding to expand its
FYI Techinvest reviewed the prelims as follows in their recent December issue:
"Frontier IP
40.5p (FIPP; AIM)
Results for the year ended June 30 showed good operational progress among the fund’s portfolio companies against a background in which valuations for unlisted tech operators softened. Net assets per share for the period decreased by 8% to 81.8p. The unrealised loss on the revaluation of investments was £0.97m compared to an unrealised gain of £10.91m in the prior year. Part-disposal of the fund’s
holding in Exscientia generated cash of £4.92m, realising a loss of £0.79m. This compares to a part-disposal of Exscientia in 2022 which generated cash of £6.53m and a profit of £2.87m. The fair value of the equity portfolio decreased by 17% to £32.97m following disposals of £5.71m and additions of £0.75m. The cash balance at the year-end was £4.6m (7.9p per share) compared to £4.37m a year earlier.
This was a resilient performance from Frontier against a challenging background for private equity valuations. The portfolio continues to mature, with several companies generating revenues, having achieved commercial traction. Others have made good industrial and technical progress and are described by Frontier as either at or reaching their inflection points.
Two new portfolio companies, Enfold Health and GraphEnergyTech, were added, and a
further one (DeakinBio) joined the portfolio after the end of the year. Despite difficult market conditions, several portfolio companies raised funds. Exscientia was the first portfolio company to list, with a good overall profit for Frontier, but others are approaching that point, including Alusid which reported that it
is exploring options for an IPO in 2024. We strongly believe that tech investors should have some exposure to private equity in the sector and Frontier is one of our favourite plays, offering a well-focused approach with good diversification
across a range of promising technologies and market segments. Subscribers can learn more about Frontier’s portfolio companies by vising the website at www.frontierip.co.uk. The shares are a strong hold."
Nice plug for Exscientia in a new article about Novo Nordisk:
Https://finance.yahoo.com/news/ozempic-drugmaker-open-ai-research-170000866.html
"It comes as a sign of Britain’s leading role in helping to develop next-generation drugs, with more biotech businesses created in the UK than anywhere else in Europe. Companies including Oxford-based Exscientia have emerged as pioneers in using AI to speed up drug discovery. Exscientia is currently working on a pill to prevent Covid.
Exscientia chief Andrew Hopkins has said the technology means it can speed up the amount of time a drug spends in development from four years to 18 months and reduce the number of experiments by around 90pc."
Premier Miton also selling
that reduces my tp...17p for oversold
Folk are heading for the exit
how long before news??
tick tock
New interview with the CEO of Vaccine Group, with some nice highlight quotes:
"several of our projects.....seeking commercial traction"
"help us with engagement from commercial partners who can take some of the products through to the marketplace"
"swine vaccines probably are the furthest forward"
"can attract a commercial partner with a little bit more progress"
"very good communication with the big animal health companies"
Https://www.proactiveinvestors.co.uk/companies/news/1036218/the-vaccine-group-appoints-advisory-board-in-partnering-push-1036218.html
If Quilters quitting
Perhaps the best way out of this mess is a better capitalised management group to buy this lot out?
tp 25p for an oversold bounce
Wilters
If they have any sense, they'll try to sell some of one of their stakes in a funding round for one of their plays
but it won't be easy
Is a fundraise on the horizon or can they monetize one of the investment early next year?
Lol
Yep, pretty chilling
when are FIPP going to show that they can generate a decent exit in the current appalling markets?
can they slash their cost base?
Lots of news flow from Pulsiv:
Oct 27th:
Https://pulsiv.co.uk/news/pulsiv-osmium-microcontrollers-now-available-through-digikey/
Great to see the behemoth Digikey now selling Pulsiv microcontrollers.
Nov 3rd:
Https://pulsiv.co.uk/news/pulsiv-nomogram-simplifies-parameter-calculations-in-dcm-flyback-designs-to-maximise-overall-efficiency/
"Combining DCM Flyback designs with a Pulsiv OSMIUM AC to DC front-end will maximise overall conversion efficiency, reduce energy waste, and lower cost in a variety of applications including USB-C devices, LED Drivers, and Battery Chargers"
Nov 6th:
Https://pulsiv.co.uk/news/pulsiv-to-exhibit-at-the-annual-power-electronics-conference-apec/
"Pulsiv is pleased to be exhibiting at the 2024 Annual Power Electronics Conference (APEC) in Long Beach CA, USA."
I've no opinion on the share price - it may indeed be a bargain. But the IC comment appears to overlook the auditors qualifying the accounts and the statement on "material uncertainty related to going concern". I think those might have had something to do with the share price reaction on the day.
FYI I've posted the IC tip here:
Https://uk.advfn.com/cmn/fbb/thread.php3?id=30281403
Conclusion:
"Effectively, the liquid stake in Exscientia and pro-forma cash are worth £6.2mn (11.1p) or a quarter of the group’s market capitalisation of £23mn (41.5p). It means that Frontier’s £33mn(59p) equity portfolio, £5.9mn (10.5p) of debt investments and £1mn (1.8p) of trade receivables are in the share price for 58 per cent less than their combined carrying valuations.That’s extremely harsh given the progress being made by both CamGraPhIC and Pulsiv Solar. In fact, I would be surprised if their combined valuation doesn’t exceed Frontier’s current market capitalisation within the next 18-24months.So, having made a case to buy Frontier’s shares,at 38p, ahead of the results (‘A tech buy on a 57 per cent discount’, 13 September 2023), I see scope for positive newsflow from portfolio companies to narrow the 50 per cent share price discount to NAV over the coming months. Buy"
Tipped by Simon yesterday afternoon.
https://www.investorschronicle.co.uk/ideas/2023/10/31/bag-a-technology-bargain-buy/
GLA
Bouncing nicely now. NAV is now 81.8p compared to the 45.5p share price.
The MMs marked the price down 5% first thing yesterday presumably based on the 8% decline in NAV year on year, but I'm happy with the overall performance - much of the NAV loss was on the sale of Exscientia shares against a lower prior year valuation, with the investment portfolio only declining by £0.96m, a pretty decent result in the current climate.
Much of the portfolio is now coming to fruition. Alusid is planning an IPO next year. A number of companies are generating revenues. Pulsiv could be a gamechanger. Others look highly promising.
FIPP has £4.6m cash and a further £2m of tradeable Exscientia shares. Which renders the qualified audit opinion somewhat odd in respect of both this and the mere 2.6% of NAV re early stage investments which the auditors were unable to conclude on in terms of valuation.
Happy to hold and add further when possible.
Can buy below the bid
tp 35p
Audit has been qualified as they haven't been able to substantiate the valuation of the stage 2 assets. It's only 3% of the assets but it's really, really poor and highlights some concerns to me around governance and controls. I continue to hold for now.
Thank you Jimmy, it is a useful summary. I hope they can make massive progress next year. Pulsiv has a potential to justify 2-3x of current market cap in medium term imo. But im big fan of Alusid and TVG too. Good luck.
Hxxps://ukstockwatch.blogspot.com/2023/10/frontier-ip-group.html
I wrote a blog about why I'm invested here. Only my opinion, but wanted to put my thoughts on paper. Would love to hear your or other opinions
Tim Moore on LinkedIn:
https://www.linkedin.com/posts/tim-moore-46766a1_as-some-of-you-have-noticed-i-have-joined-activity-7114896087261270016-8jNp?utm_source=share&utm_medium=member_android